On May 17, Mr. Juan Carlos Trujillo, Director of Operations and International Policy of the Latin American Federation of the Pharmaceutical Industry (FIFARMA), moderated a panel of experts at the 12th Annual Congress of Eyeforpharma Latam.
The so called Multi-Stakeholder Panel was attended by four key players in the pharmaceutical industry: Eduardo Magallanes, Senior Vice President of Bayer Pharmaceuticals; Migdalia Denis, Founder and President of the Latin Society of Pulmonary Hypertension; Eva María Ruiz de Castilla, Director of GAfPA Latin America and Dr. Laura Suchil, Head of the Institutional Liaison Department of the National Cancer Institute of Mexico.
The topics addressed highlighted the importance of strengthening the links and collaboration among the main actors of health systems so that health care works and meets current needs.
“The governments of the region have a huge challenge ahead because they have to establish what are the priorities of investment with limited budgets,” appointed Juan Carlos Trujillo.
In addition, the executive urged to strengthen standards and promote good practices in the industry. “In Latin America, the main buyers and enablers of medicines are governments and we must develop policies and initiatives together to reach agreements that benefit patients”, he said.